A simple HPLC method for the determination of caffeine and theophylline in plasma is described. Separation of theobromine, paraxanthine, theophylline,~-hydroxyethyltheophyllineand caffeine is obtained using a mobile phase of 1% acetic acid/methanol (83: 17, v/v) and a Waters Associates NOVA-PAK ClK column protected by a Guard-PAK precolumn module containing a Guard-PAK CN cartridge. Rapid sample preparation is achieved by solid-phase extraction columns (Bond-Elut CIK, I mL capacity) which provide excellent recovery values for both drugs. The cost per sample using this approach can be minimised by column regeneration and re-use. Results obtained for theophylline are in good agreement with values determined by other techniques.
Theophylline is a potent bronchodilator and respiratory stimulant effective in the treatment of bronchial asthma. I It is widely recognised that individual patient drug level monitoring is necessary to ensure maximum clinical response and to avoid the undesirable side effects associated with theophylline overdose. This is a consequence of the variable pharmacokinetics of theophylline between patients/ which may be influenced by factors such as smoking, diet, additional medications and various diseases, differences in anhydrous theophylline content among available dosage forms and patient non-compliance.
In recent years both theophylline and caffeine have become increasingly used in the treatment of neonatal apnoea': 4 and therapeutic drug monitoring is even more appropriate in this situation. This is due to major differences in the metabolism and pharmacokinetic parameters of these drugs in neonates as compared with older children and adults.i': 6 together with uncertainty regarding contributions derived from maternal dietary sources.": K Despite theophylline being a metabolite of Correspondence: Clare E Pickard, Department of Chemical Pathology, University of Leeds, Clarendon Wing, The General Infirmary at Leeds, Leeds LS2 9NS, UK. 440 caffeine in adults," it is partially converted by N-methylation to caffeine in premature newborns Ill, II and the interconversion of these two clinically important methylxanthines observed in neonates by Bada et al.•12 has been confirmed using isotopically labelled drugs. 13 The presence of methylxanthines in the plasma of newborns may also result from transplacental transfer of caffeine or from ingestion of breast milk. Indeed, in a recent study," cord blood levels of caffeine and its N-demethylated metabolites were found to be higher than previously indicated, 14 whilst a survey of breast fed babies showed that plasma caffeine levels reflected the caffeine content of their mother's milk." Since caffeine and theophylline are both pharmacologically active, it is essential during therapeutic drug monitoring of neonates to be able to determine both drugs simultaneously. This requirement is clearly illustrated by a recent report of caffeine reaching clinically significant levels in the neonate during theophylline therapy. 15 Various analytical techniques have been used for the determination of caffeine and theophylline in biological fluids. These include spectrophotometry, 16. 17 gas liquid chromatography (GLC), 1K-211 radioimmunoassay (RIA),21 homogeneous enzyme immunoassay (EMIT),22 HPLC 7, 2J-2K and, more recently, fluorescence polarisation immunoassay (FPIA).29 Spectrophotometric assays, however, require large sample volumes and are subject to interferences!": 17 whilst GLC procedures, in addition to using large volumes of plasma, generally have lengthy analysis times and low sensitivity.I!>-211 The RIA, EMIT and FPIA techniques 'also have limited applicability since they do not currently permit the simultaneous determination of caffeine and theophylline.?': 22, 29 By comparison, HPLC provides a simple, sensitive and specific approach capable of measuring caffeine and theophylline simultaneously. Although HPLC has been used extensively for the purpose of measuring caffeine and theophylline in plasma, many methods are only suitable for estimating one or other of the methylxanthines. Furthermore, paraxanthine (the principal metabolite derived from caffeine by Nsdemethylation") tends to co-elute with theophylline under many HPLC solvent conditions. However, improved HPLC assays which permit the simultaneous determination of caffeine and its N-demethylated metabolites in plasma have been developed recently." 2J-2K Unfortunately, the majority of these either involve relatively long retention times or require lengthy extraction procedures.
The present method explores the use of solid phase extraction columns (Bond-Elut C IK, 1 mL capacity) to achieve rapid sample preparation. Using this approach, the need for solvent evaporation followed by reconstitution in mobile phase prior to analysis can be eliminated, thus providing a significant improvement over alternative extraction methods.": 23. 25-27 Excellent separation of caffeine, theophylline, paraxanthine and theobromine is provided, relatively quickly, by reversed-phase chromatography'" without any requirement for tetrahydrofurarr" or ion pairing reagentsf' in the mobile phase. The HPLC results obtained were compared with those provided by two alternative methods currently used in clinical chemistry laboratories for measuring plasma theophylline levels, namely EMIT and FPIA.
Materials and methods

EQUIPMENT
The Waters Associates' high-performance liquid chromatograph consisted of a Model 510 pump in conjunction with a U6K injector and a Lambda-Max Model 481 variable wavelength LC spectrophotometer operating at 273 nm A rapid HPLC method 441 which was connected to a Model 730 Data Module (Millipore Ltd, Harrow, UK). Chromatography was performed using a Waters Associates' Z-Module RCSS system containing a radially compressed NOVA-PAK™ C lK Radial-Pak Cartridge (8 mm IDxl0 ern). The analytical column (fully capped, 4-~m spherical, C IK bonded silica) was protected by incorporating into the system a Waters Associates' Guard-PAK™ precolumn module containing a Guard-PAK CN™ cartridge.
CHEMICALS AND REAGENTS
Caffeine, theophylline, paraxanthine, theobromine and l:3-hydroxyethyl-theophylline were supplied by Sigma Chemical Co., Poole, Dorset, UK. Methanol (HPLC grade) was obtained from Rathburn Chemicals, Walkerburn, Scotland. Glacial acetic acid (Aristar quality), disodium hydrogen phosphate and orthophosphoric acid (Analar grade) were purchased from BDH Chemicals, Poole, UK. Bovine serum albumin was supplied by Armour Pharmaceutical Company, Eastbourne, UK. Ortho I and II Bilevel Anticonvulsant! Antiasthmatic quality control material was acquired from Ortho Diagnostics, High Wycombe, UK. Bond-Elut™ C 1K columns, 1 mL capacity and the special Vac-Elut" vacuum apparatus are both manufactured by Analytichem International, Harbor City, California, USA and supplied by Jones Chromatography, Llanbradach , UK. EMIT theophylline assay kits were purchased from Syva, Maidenhead, UK.
Stock solutions of caffeine and theophylline (1 g/L in 1% acetic acid) were diluted further with 1% acetic acid to a final concentration of 100 mg/L, From these, working standards were produced by dilution with 3% bovine serum albumin (3 g BSA in 100 mL distilled water) providing final theophylline and caffeine concentrations of 10, 20 and 30 mg/L, The internal standard, l:3-hydroxyethyltheophylline was prepared in 0·1 M phosphate buffer, pH 4·0, and used at a concentration of 15 mg/L, The mobile phase consisting of 1% glacial acetic acid/methanol (83:17 v/v) was filtered through a 0·45 urn Millipore filter (type HA) and degassed prior to use. Chromatography was performed at ambient temperature using a flow rate of 2·7 mUmin which produced a back pressure of approximately 120 bars. (4) and caffeine (5) in 3% BSA at concentrations of 2·5 ug/rnl, for each of the dimethylxanthine components, and 10 ug/ml, and 6 I-lglmL for~ hydroxyethyltheophylline and caffeine, respectively. (b) Chromatogram of extracted plasma obtained from a patient after approximately 2 weeks on a caffeine-free diet. The extraction procedure and chromatographic conditions were as described in the text. 
METHOD
Rapid extraction of caffeine and theophylline
Results
A chromatogram obtained following injection of a mixture of caffeine, 6-hydroxyethyltheophylline (internal standard), theophylline, paraxanthine and theobromine (in 3% BSA) is illustrated in Fig. 1a . Excellent resolution of all components was achieved in approximately 8 min; the retention times of individual methylxanthines, together with those of some commonly prescribed drugs and preparations used in paediatric medicine, are listed in Table 1 . Comparison of the retention data contained in Table 1 clearly shows that these potentially interfering compounds do not prevent the accurate quantitation of caffeine or from serum or plasma was achieved using reversed-phase octadecylsilane bonded silica columns (Bond-Elut CiS, 1 mL capacity). These were conditioned immediately prior to use in accordance with the manufacturer's instructions, by drawing two column volumes (Zx 1 mL) of methanol followed by a similar volume of water through the column under vacuum. On releasing the vacuum, 100 IJ-L of the serum sample followed by 100 IJ-L of the internal standard solution were loaded onto the column. After standing for 1 min the sample was drawn through the column by re-applying the vacuum. The vacuum was then released, allowing an equilibration period of 2 min before proceeding to the washing stage. This consisted of drawing two column volumes (2X1 mL) of water through the column under vacuum. Caffeine and theophylline were eluted from the Bond-Elut CiS column with 400 IJ-L of methanol. 10 IJ-L aliquots of the methanolic extract were injected directly into the chromatograph and peak heights measured at a spectrophotometer setting of 0·01 absorbance units full scale deflection. Large numbers of samples were conveniently handled using a special Vac-Elut vacuum apparatus which allowed 10 columns to be used simultaneously. Samples were loaded onto the columns under vacuum at controllable flow rates and on completion of the washing procedure, the drug was eluted from the columns into tubes held in a rack within the vacuum apparatus. Finally, the vacuum was released allowing the fractions collected to be removed for analysis by HPLC. However, this special vacuum apparatus would not necessarily be required for carrying out extractions on small numbers of samples in the clinical situation.
theophylline. The chromatogram represented in Figure 1b is that of extracted plasma obtained from an adult male patient after abstaining from caffeine-containing beverages for approximately 2 weeks. Although an unknown component (X) occurs in all extracted serum and plasma samples, it elutes between the internal standard and caffeine peaks with a retention time in the region of 6-7 min and clearly does not interfere with the estimation of caffeine or theophylline.
The recovery of caffeine and theophylline was calculated after extracting two series of replicate samples ( Table 2 ). These were prepared in 3% BSA so that they contained either 10 mg/L or 20 mg/L of each component, respectively. The extraction efficiency was determined by comparing the peak heights obtained when these samples were subjected to the previously described procedure and subsequently chromatographed, with those from injections of standard solutions. The mean recovery of caffeine was 102·1% and 100·0% at the low and high concentrations, respectively. The values for theophylline at the same concentrations were 98·5% and 95·6%, respectively. Calibration curves were linear over the concentration range 0-30 mg/L for each compo- nent. The correlation coefficients (r) between concentration and peak height ratio obtained from extracted standards prepared in 3% BSA to adequately cover the above range, were 0·997 for caffeine and 0·999 in the case of theophylline (n=13 for both components).
Some information about the accuracy of the method was obtained by including commercial quality control samples (Ortho I and II) in each batch of samples analysed. However, as commercial quality control sera containing caffeine were not available, the data generated is for theophylline only. Expected mean values for Ortho I and II by HPLC were 10·0 mgIL and 18·8 mgIL, respectively, whilst mean values determined were 9·8 mgIL (range 9·6-9·9 mgIL) and 19·2 mg/L (range 19·0-20·0 mg/L) for n=3 and n=5 determinations, respectively. It can be seen, therefore, that there is no obvious bias at either low or high theophylline concentrations.
The precision of the method was examined by analysis of two series of replicate samples both within-batch and between-batch. These were prepared in 3% BSA and contained the same concentrations of caffeine and theophylline as those used to determine the efficiency of the extraction procedure. Storage of samples prior to analysis was at -20°C, because under these conditions stability has been established at approximately 3-6 months. The results presented in Table 3 indicate that the precision of the method is perfectly adequate for routine use since within-batch coefficients of variation are less than 2% and between-batch figures are less than 5% for both components (n=5 and n=6, respectively).
The HPLC method was compared with both the EMIT and FPIA techniques (as described by the kit manufacturers) by analysing 25 serum samples using all three methods. Samples from adults on theophylline medication were used rather than samples from children because of the large sample volumes required to perform three separate analyses. As reagent kits for the analysis of caffeine by EMIT and FPIA were not available it was only possible to compare theophylline values which ranged from 0·5 to 31·0 mglL as measured by EMIT (mean 9·6; SD 7·6 mgIL). It is evident from Table 4 that there is a good correlation between results obtained using all three methods with no significant differences between any of the methods.
Discussion
The method described is particularly suitable for therapeutic drug monitoring applications in the treatment of neonatal apnoea, where the simultaneous determination of caffeine and theophylline in plasma is clearly indicated, and could also be applied to adults. Separation of caffeine, theophylline, paraxanthine and theobromine, together with the internal standard, is provided in under 8 min without any requirement for tetrahydrofuran in the mobile phase. 13, 32 In addition, the absence of buffered salt solutions from the mobile phase eliminates the need for pH adjustment and reduces the risk of problems with blocked frits and filters resulting from inadequate washing of the HPLC system following use. Furthermore, the use of acetonitrile which is both toxic when inhaled and a skin irritant, as well as being relatively expensive, is avoided.
Although there are a variety of procedures available for extracting caffeine and theophylline from biological fluids, the majority of methods employ solvent extraction. This usually involves shaking the sample with a suitable solvent containing the internal standard, followed by centrifugation to achieve phase separation and finally, solvent evaporation and reconstitution in mobile phase prior to analysis. Alternatively, protein precipitation frocedures have been used with some success/ and occasionally direct injection of diluted plasma or serum has been employed. 3D However, the solid phase extraction described eliminates the need for sample evaporation prior to analysis because the sensitivity of the assay permits direct injection of the methanolic extract into the chromatograph. Thus, sample preparation is reduced to a minimum compared with solvent extraction techniques": 23. 26. 27 and problems of drug interferences and column deterioration encountered with some protein precipitation and direct injection procedures 30 -32 aresavoided. Although the principle ofthe solid phase extraction technique is related to those previously described for caffeine'" or theophyllinev'" the optimum protocol for good recovery has been independently determined in our laboratory. 28 The cost of solid phase extraction columns may be reduced by repetitive use since regeneration of the columns can be effected quite easily. This is achieved by simply washing with two column volumes of a polar solvent (e.g. methanol) immediately following use. The effects of repetitive use of these extraction columns following regeneration were assessed by re-using the columns up to five times each. The results, presented in Table 2 , compare adequately with those established following single extraction, although there is some decline in peformance. It would appear, therefore, that jhe recovery and variability of the extraction is not seriously affected by repetitive use up to the maximum of five extractions tested.
In this study, recovery and precision data are based on the analysis of standard solutions prepared in 3% bovine serum albumin. Satisfactory recovery and reproducibility in the extraction of both theophylline and caffeine from plasma by this technique have already been demonstrated. The validity of using 3% BSA as a convenient way of avoiding the difficulties inherent in obtaining caffeine-free plasma for calibration purposes has also been established, and we advocate this strongly. 2M Recovery values obtained using solid phase extraction colums (> 91% for both components at the concentration levels studied) are in good agreement with those reported for solvent extraction procedures." 23. 26, 27 The accuracy and precision of the method are acceptable, the calibration graph is linear over the working range (0-30 mg/L) and the sensitivity is more than adequate (detection limit in the region of 500 ug/L for caffeine). In addition, there appears to be no interference from a variety of commonly prescribed drugs listed in Table 1 . Finally, the excellent agreement between results obtained using HPLC, EMIT and FPIA during the comparison of these techniques, summarised in Table 4 , clearly demonstrates the suitability of the method described for routine therapeutic drug monitoring applications.
